Abstract:We previously found that apolipoprotein E (APOE) ∊4 gene dose, reflecting three levels of genetic risk for late-onset Alzheimer's disease (AD), is associated with characteristic patterns of glucose hypometabolism and fibrillar amyloid-beta (Aβ) burden in cognitively normal older adults (Reiman et al, 2004; 2009). We have also introduced an automated algorithm, known as multi-modal partial least squares (MMPLS), to characterize the linkage between patterns in two or more complementary complex data sets from the same person on a voxel-by-voxel basis (Chen et al, 2009). In this study, we used MMPLS to characterize how APOE ∊4 gene dose is associated with patterns of cerebral hypometabolism and fibrillar Aβ burden. We investigated how metabolic and Aβ measurements, in respective clusters of preferentially affected voxels, are related to each other. MMPLS was used in “informed mode” for the simultaneous analysis of fluorodeoxyglucose (FDG) and Pittsburgh Compound B (PiB) positron emission tomography (PET) images from 11 ∊4 homozygotes, 11 ∊4 heterozygotes, and 16 ∊4 noncarriers who were cognitive normal (65 ± 5 years old). Patterns of cerebral-to-whole brain FDG PET counts and cerebral-to-cerebellar PiB Distribution Volume Ratios (DVRs) most closely associated with APOE ∊4 gene dose were characterized. ∊4 homozygote, heterozygote, and non-carrier groups did not differ significantly in their age, gender distribution, educational level, Mini-Mental State Examination scores (29.6 ± 0.8), or Auditory Verbal Learning Test long-term memory scores. Patterns most closely associated with APOE ∊4 gene dose were notable for lower glucose metabolism in the precuneus and posterior cingulate cortex and increased fibrillar Aβ in the precuneus, posterior cingulate cortex and medial prefrontal cortex. As expected, there was a strong correlation between lower cerebral glucose metabolism and higher fibrillar Aβ in respective empirically defined statistical regions-of-interest (comprised of voxels associated with ∊4 gene dose at p≤0.005) in all 38 subjects (r = -0.46, p = 0.0039) and in the 22 ∊4 carriers (r = -0.47, p = 0.028). Larger sample sizes are needed to further characterize the relationships for each APOE genotype. There is a strong relationship between the pattern of regional hypometabolism and fibrillar Aβ deposition associated with three levels of genetic risk for late-onset AD in cognitively normal adults.

Higher Serum Total Cholesterol Levels in Late Middle Age Are Associated with Glucose Hypometabolism in Brain Regions Affected by Alzheimer'S Disease and Normal Aging

Correlations Between Cholesterol-Related Genetic Risk Scores and Lower Brain-Imaging Measurements of Regional Glucose Metabolism

Cholesterol-related Genetic Risk Scores Are Associated with Hypometabolism in Alzheimer's-affected Brain Regions.

Higher Serum Glucose Levels Are Associated with Cerebral Hypometabolism in Alzheimer Regions

Investigating the Association Between Fasting Serum Glucose Levels and Cerebral Metabolic Rate for Glucose in Brain Regions Affected by Alzheimer's Disease

Association Between Longitudinal Increases in Serum Glucose and Metabolic Decline in Azheimer’s Disease-Related Brain Regions (P6.321)

Longitudinal Changes in Serum Glucose Levels Are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions

Association Between Cerebral Patterns of Fibrillar Beta-Amyloid Burden and Glucose Hypometabolism in Cognitively Normal Older Adults at Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease

Blood Pressure is Associated with Higher Brain Amyloid Burden and Lower Glucose Metabolism in Healthy Late Middle-Age Persons

Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease.

P1-259: Regional Hypometabolism in Cognitively Normal Hispanic Carriers of the Apolipoprotein E-ϵ4 Allele

IC‐P‐122: Association Between an Alzheimer's Disease‐Related Hypometabolic Convergence Index in Cognitively Normal Late‐Middle‐Aged People and Three Levels of Genetic Risk for Late‐Onset Alzheimer's Disease

Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism

P2‐243: Higher BMI is Associated with Greater Cerebral Glucose Metabolism in Late Middle‐Aged and Elderly Subjects Regardless of APOE Ε4 Genotype

Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism

Elevated blood glucose levels are associated with the progression of brain hypometabolism, and HDL-C and APOE4 add to this association

Association Between Higher Fasting Serum Glucose Levels and the Pattern of Lower Regional Gray Matter Volumes in Cognitively Normal Adults

Hypometabolism in Alzheimer-affected Brain Regions in Cognitively Healthy Latino Individuals Carrying the Apolipoprotein E Epsilon4 Allele.

Declining Brain Activity in Cognitively Normal Apolipoprotein E Epsilon 4 Heterozygotes: A Foundation for Using Positron Emission Tomography to Efficiently Test Treatments to Prevent Alzheimer's Disease.

Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE Ɛ3/ɛ4 Carriers.

Brain Imaging Measurements of Fibrillar Amyloid-Β Burden, Paired Helical Filament Tau Burden, and Atrophy in Cognitively Unimpaired Persons with Two, One, and No Copies of the APOE Ε4 Allele